| 1. |
Butler G, Rasmussen MD, Lin MF, et al. Evolution of pathogenicity and sexual reproduction in eight candida genomes. Nature, 2009, 459(7247): 657-662.
|
| 2. |
Satoh K, Makimura K, Hasumi Y, et al. Candida auris sp. nov. , a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol, 2009, 53(1): 41-44.
|
| 3. |
Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis, 2017, 64(2): 134-140.
|
| 4. |
Szekely A, Borman AM, Johnson EM. Candida auris Isolates of the Southern Asian and South African lineages exhibit different phenotypic and antifungal susceptibility profiles in vitro. J Clin Microbiol, 2019, 57(5): e02055-18.
|
| 5. |
Schelenz S, Hagen F, Rhodes JL, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control, 2016, 5: 35.
|
| 6. |
Amer HA, AlFaraj S, Alboqami K, et al. Characteristics and mitigation measures of Candida auris infection: descriptive analysis from a quaternary care hospital in Saudi Arabia, 2021–2022. J Epidemiol Glob Health, 2023, 13(4): 825-830.
|
| 7. |
Larkin E, Hager C, Chandra J, et al. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother, 2017, 61(5): e02396-16.
|
| 8. |
Wang X, Bing J, Zheng Q, et al. The first isolate of Candida auris in China: clinical and biological aspects. Emerg Microbes Infect, 2018, 7(1): 93.
|
| 9. |
Fan S, Zhan P, Bing J, et al. A biological and genomic comparison of a drug-resistant and a drug-susceptible strain of Candida auris isolated from Beijing, China. Virulence, 2021, 12(1): 1388-1399.
|
| 10. |
Bing J, Wang S, Xu H, et al. A case of Candida auris candidemia in Xiamen, China, and a comparative analysis of clinical isolates in China. Mycology, 2022, 13(1): 68-75.
|
| 11. |
Bing J, Du H, Guo P, et al. Candida auris -associated hospitalizations and outbreaks, China, 2018–2023. Emerg Microbes Infect, 2024, 13(1): 2302843.
|
| 12. |
Tian S, Rong C, Nian H, et al. First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China. Emerg Microbes Infect, 2018, 7(1): 128.
|
| 13. |
中華醫學會檢驗分會臨床微生物學學組. 成人耳念珠菌感染診治防控專家共識. 臨床檢驗雜志, 2020, 38(8): 564-570.
|
| 14. |
Tian S, Bing J, Chu Y, et al. Genomic epidemiology of Candida auris in a general hospital in Shenyang, China: a three-year surveillance study. Emerg Microbes Infect, 2021, 10(1): 1088-1096.
|
| 15. |
Mu?oz JF, Gade L, Chow NA, et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat Commun, 2018, 9(1): 5346.
|
| 16. |
Hou X, Lee A, Jiménez-Ortigosa C, et al. Rapid detection of ERG11 -associated azole resistance and FKS -associated echinocandin resistance in Candida auris. Antimicrob Agents Chemother, 2019, 63(1): e01811-18.
|
| 17. |
Morio F, Loge C, Besse B, et al. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn Microbiol Infect Dis, 2010, 66(4): 373-384.
|
| 18. |
Keighley C, Garnham K, Harch SAJ, et al. Candida auris: diagnostic challenges and emerging opportunities for the clinical microbiology laboratory. Curr Fungal Infect Rep, 2021, 15(3): 116-126.
|
| 19. |
Gu W, Deng X, Lee M, et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids. Nat Med, 2021, 27(1): 115-124.
|
